GE Healthcare has partnered with Sweden-based Karolinska University Hospital, to help improve the efficiency of the care pathway for pelvic cancer patients and reduce unwarranted clinical variation.
Under the deal, GE Healthcare will offer consultancy services, tools for healthcare analytics and a PET/CT imaging platform to the hospital.
The contract is for a period of 14 years, and an option has been provided to extend it for further six.
GE Healthcare Northern Europe general manager Karl Blight said: "Currently, each care pathway for each pelvic cancer is being managed separately by specialties such as surgeons, urologists, gynaecologists, but they all converge at various points in the pathway.
"This represents an important opportunity for knowledge transfer between specialties and delivering improvements in value-based healthcare across multiple care pathways."
The deal will allow the hospital access with a Caradigm intelligence platform (CIP) from Caradigm, a joint venture of GE Healthcare and Microsoft.
This platform will be used to combine data, including clinical patient data, financial and operational data, from different systems, which will help in better clinical decision support, analysis and prediction.
According to GE, the PET/CT technology will be used in the pelvic cancer patient pathway, ranging from diagnosis to disease staging and treatment monitoring.
Throughout the whole contract period, GE will continue to update the imaging platform with advanced technology.
Image: Karolinska Solna – Hospital in Stockholm. Photo: courtesy of Holger.Ellgaard.
